The combination of adjuvant chemotherapy and endocrine therapy is no more effective than endocrine therapy alone in improving survival outcomes in patients with early-stage invasive lobular breast cancer, Cleveland Clinic investigators have found.
Managing patients who develop genitourinary syndrome of menopause while on endocrine therapy for breast cancer can be complex. In this article, Cleveland Clinic specialists discuss their proactive, comprehensive approach, including the latest nonhormonal and local therapies.
Immunotherapy hasn’t benefited breast cancer patients — yet. Breast medical oncologist Megan Kruse, MD, explains how that may be changing.